In this ninth installment of Rockefeller Client Insights, Greg Fleming interviews Ginkgo Bioworks Co-Founder and CEO, Dr. Jason Kelly. The dialogue focuses on private sector innovation surrounding COVID-19. Introduction by Thomas Martella, AVP, Platform Development at Rockefeller Capital Management. Originally broadcast live May 28, 2020.